Evidence map›Paper›PMID 32147816›Full record

ArticleBritish journal of haematology2020

Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.

Vera Adema, Laura Palomo, Andrea Toma, Olivier Kosmider, Francisco Fuster-Tormo, Rocío Benito, Rocío Salgado, Esperanza Such, María José Larrayoz, Blanca Xicoy and 10 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Vera AdemaMDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.ORCID 0000-0001-6051-4378
Laura PalomoMDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.ORCID 0000-0003-3176-6271
Andrea TomaAssistance Publique - Hôpitaux de Paris, Service Hematologie Clinique, Hôpital Universitaire Henri Mondor, Creteil, France.
Olivier KosmiderAssistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.
Francisco Fuster-TormoMDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
Rocío BenitoUnidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.
Rocío SalgadoLaboratorio de Citogenetica, Servicio de Hematología, Hospital Universitario fundación Jimenez Díaz, Madrid, Spain.
Esperanza SuchHematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID 0000-0001-6892-403X
María José LarrayozDepartment of Genetics, School of Medicine, University of Navarra, IDISNA, Pamplona, Spain.
Blanca XicoyHematology Service, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain.ORCID 0000-0002-0295-1307
Jesus Maria Hernandez-SanchezUnidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.
Paolo MaiettaScientific & Innovation Department, Nimgenetics, Madrid, Spain.
Alexander NeefHematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Michaela FontenayAssistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.
Mariam IbañezHematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Maria Diez-CampeloUnidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.ORCID 0000-0002-1467-6779
Sara AlvarezScientific & Innovation Department, Nimgenetics, Madrid, Spain.
Jaroslaw P MaciejewskiDepartment of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Pierre FenauxAssistance Publique-Hopitaux de Paris, Service d'Hematologie Biologique, Hopitaux Universitaires Paris Centre, Paris, France.ORCID 0000-0002-0468-3553
Francesc SoleMDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
Universitat Autònoma de Barcelona · ESAssistance Publique – Hôpitaux de Paris · FRUniversidad Cardenal Herrera CEU · ESUniversidad de Salamanca · ESCleveland Clinic · USHospital Universitario Fundación Jiménez Díaz · ESUniversidad de Navarra · ES

Funding

Therapeutic Implications of Molecular Defects in Bone Marrow FailureR35HL135795 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P. · 2017 to 2023
$5.7M
Novel Spliceosomal Defects in Myelodysplastic SyndromesR01HL132071 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P., PADGETT, RICHARD A · 2016 to 2019
$2.4M
Celgene SpainCERCA Program/Generalitat de CatalunyaFundación Española de Hematología y HemoterapiaInstituto de Salud Carlos III, Ministerio de Economia y Competividad, Spain PI/14/00013Instituto de Salud Carlos III, Ministerio de Economia y Competividad, Spain PI/17/0575la CaixaNHLBI NIH HHS R01 HL132071NHLBI NIH HHS R35 HL135795
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansLenalidomideMutationMyelodysplastic SyndromesLenalidomidedel(5q)lenalidomidemutationsMyelodysplastic syndromesnon-del(5q)

Identifiers

PMID32147816
PMCPMC8370477
OpenAlexW3009968822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.